1. Fill the market gap and invest to accelerate the market development: American Eljian Company's products involve ophthalmology, neuroscience, medical dermatology and urology, which have a high market share and great development potential. Aijian company occupies a leading position in the field of medical beauty, producing the most attractive product portfolio in this field and providing a world-class obesity intervention product production line.
2. Balanced R&D product portfolio: American Eljian Company has invested heavily in R&D and developed many new products and indications with great market potential to promote long-term business growth. The latest submitted and approved new drugs/indications are the best evidence.
3. Unique management skill set: The management team of American Elgin Company has professional knowledge in pharmacy, biology, medical devices and consumer goods. Under the leadership of David E. I. Pyott, Chairman and CEO of the Board of Directors, Aijian Company has managed flexibly and successfully predicted and responded to market demand for many times.
4. Strategic company layout: American Eljian Company has gathered the best and unique business model recognized in various fields, namely, lean operation scale, high growth characteristics in special fields, diversified product portfolio, global comprehensive R&D capability comparable to that of larger pharmaceutical companies, and abundant follow-up biochemical new products. The proper scale of American Eljian company can not only mobilize sufficient resources, but also ensure rapid implementation and close contact with customers.